Clearance Summary
ANTI-VIMENTIN PRIMARY ANTIBODY received FDA 510(k) clearance under submission number K941397, sponsored by Ventana Medical Systems, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1997-02-10.
- Submission: K941397
- Applicant / Sponsor: Ventana Medical Systems, Inc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5550
- Decision date: 1997-02-10
Classification & Regulation
This clearance is catalogued under FDA product code DEH and 21 CFR 866.5550, within the Immunology review panel as a Class II device.